| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HPQ | Common Stock | Options Exercise | $0 | +20,447 | $0.000000 | 20,447 | 07 Dec 2021 | Direct | ||
| transaction | HPQ | Common Stock | Tax liability | $169,110 | -4,535 | -22% | $37.29 | 15,912 | 07 Dec 2021 | Direct | F1 |
| transaction | HPQ | Common Stock | Sale | $573,787 | -15,912 | -100% | $36.06 | 0 | 09 Dec 2021 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HPQ | Restricted Stock Units | Award | +14,749 | 14,749 | 07 Dec 2021 | Common Stock | 14,749 | Direct | F3, F4 | ||||
| transaction | HPQ | Restricted Stock Units | Options Exercise | -3,616 | -34% | 7,038 | 07 Dec 2021 | Common Stock | 3,616 | Direct | F3, F5 | |||
| transaction | HPQ | Restricted Stock Units | Options Exercise | -8,762 | -52% | 8,212 | 07 Dec 2021 | Common Stock | 8,762 | Direct | F3, F6 | |||
| transaction | HPQ | Restricted Stock Units | Options Exercise | -8,069 | -100% | 0 | 07 Dec 2021 | Common Stock | 8,069 | Direct | F3, F7 |
| Id | Content |
|---|---|
| F1 | Shares withheld by HP to satisfy tax withholding upon vesting. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.04-$36.075, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. |
| F4 | On 12/7/2021, the reporting person was granted 14,749 RSUs, one-third of which vest annually over three years on each of 12/7/2022, 12/7/2023 and 12/7/2024. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. |
| F5 | As previously reported, on 12/7/2020, the reporting person was granted 10,557 RSUs, 3,519 of which vested on 12/7/2021, and 3,519 of which is scheduled to vest on each of 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 97 vested dividend equivalent rights. |
| F6 | As previously reported, on 12/6/2019, the reporting person was granted 24,634 RSUs, 8,211 of which vested on each of 12/7/2020 and 12/7/2021, and 8,212 of which is scheduled to vest on 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 551 vested dividend equivalent rights. |
| F7 | As previously reported, on 12/7/2018, the reporting person was granted 22,024 RSUs, 7,341 of which vested on each of 12/7/2019 and 12/7/2020 and 7,342 of which vested on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 727 vested dividend equivalent rights. |